Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

[Principles of postoperative therapy in rectal carcinoma].

Folprecht G, Köhne CH.

Chirurg. 2004 Jan;75(1):32-7. German.

PMID:
14740125
2.

[Preoperative radiochemotherapy for rectal cancer: forecasting the next steps through ongoing and forthcoming studies].

Créhange G, Bosset JF, Maingon P.

Cancer Radiother. 2011 Oct;15(6-7):440-4. doi: 10.1016/j.canrad.2011.05.006. Epub 2011 Jul 28. Review. French.

PMID:
21802334
3.

[The new chemotherapy of colorectal cancers].

Taïeb J, Boige V, Ducreux M.

Presse Med. 2002 Jan 26;31(3):132-8. Review. French.

PMID:
11859739
4.

Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicentre, phase 2, randomised controlled trial.

Hong YS, Nam BH, Kim KP, Kim JE, Park SJ, Park YS, Park JO, Kim SY, Kim TY, Kim JH, Ahn JB, Lim SB, Yu CS, Kim JC, Yun SH, Kim JH, Park JH, Park HC, Jung KH, Kim TW.

Lancet Oncol. 2014 Oct;15(11):1245-53. doi: 10.1016/S1470-2045(14)70377-8. Epub 2014 Sep 4.

PMID:
25201358
5.

[Chemotherapy and rectal cancer].

Michel P, Di Fiore F.

Cancer Radiother. 2011 Oct;15(6-7):436-9. doi: 10.1016/j.canrad.2011.06.002. Epub 2011 Aug 31. Review. French.

PMID:
21885319
6.

Postoperative adjuvant chemotherapy in rectal cancer operated for cure.

Petersen SH, Harling H, Kirkeby LT, Wille-Jørgensen P, Mocellin S.

Cochrane Database Syst Rev. 2012 Mar 14;(3):CD004078. doi: 10.1002/14651858.CD004078.pub2. Review.

PMID:
22419291
7.

Integration of novel agents into combined-modality treatment for rectal cancer patients.

Rödel C, Sauer R.

Strahlenther Onkol. 2007 May;183(5):227-35. Review.

PMID:
17497093
8.

Combined-modality therapy of rectal cancer with irinotecan-based regimens.

Minsky BD.

Oncology (Williston Park). 2004 Dec;18(14 Suppl 14):49-55. Review.

9.

[Preoperative treatments of rectal cancers].

Bosset JF, Nguyen F, Bosset M, Servagi-Vernat S, Sedrati A, Lorgis V.

Cancer Radiother. 2007 Nov;11(6-7):349-52. Epub 2007 Sep 25. Review. French.

PMID:
17897858
10.

Adjuvant therapy for stage II and III colorectal cancer.

de Gramont A, Tournigand C, André T, Larsen AK, Louvet C.

Semin Oncol. 2007 Apr;34(2 Suppl 1):S37-40.

PMID:
17449351
11.
12.

Radiotherapy for localized rectal cancer.

Deutsch E, Ezra P, Mangoni M, Ducreux M.

Ann Oncol. 2007 Jul;18 Suppl 9:ix105-13. Review. No abstract available.

PMID:
17631562
13.

[Value of postoperative adjuvant chemotherapy in locally advanced rectal cancer patients with ypT1-4N0 after neo-adjuvant chemoradiotherapy].

You KY, Peng HH, Gao YH, Chen L, Zhou GQ, Chang H, Du XJ, Xiao L, Zeng ZF, Wen BX, Liu MZ.

Zhonghua Zhong Liu Za Zhi. 2013 Sep;35(9):708-13. Chinese.

PMID:
24332061
14.

Efficacy endpoints of radiation therapy group protocol 0247: a randomized, phase 2 study of neoadjuvant radiation therapy plus concurrent capecitabine and irinotecan or capecitabine and oxaliplatin for patients with locally advanced rectal cancer.

Wong SJ, Moughan J, Meropol NJ, Anne PR, Kachnic LA, Rashid A, Watson JC, Mitchell EP, Pollock J, Lee RJ, Haddock M, Erickson BA, Willett CG.

Int J Radiat Oncol Biol Phys. 2015 Jan 1;91(1):116-23. doi: 10.1016/j.ijrobp.2014.09.031. Epub 2014 Nov 5.

15.

Adjuvant versus neoadjuvant radiochemotherapy for locally advanced rectal cancer. A progress report of a phase-III randomized trial (protocol CAO/ARO/AIO-94).

Sauer R, Fietkau R, Wittekind C, Martus P, Rödel C, Hohenberger W, Jatzko G, Sabitzer H, Karstens JH, Becker H, Hess C, Raab R.

Strahlenther Onkol. 2001 Apr;177(4):173-81.

PMID:
11370551
16.

Risk-adapted adjuvant chemotherapy after concomitant fluoropyrimidine-radiotherapy neoadjuvant treatment for patients with resectable cT3-4 or N+ rectal cancer.

Sastre J, Custodio A, Sanchez JC, Ortega L, Rodriguez L, Puente J, Corona J, Alfonso R, de las Heras M, Dıaz-Rubio E.

Anticancer Drugs. 2011 Feb;22(2):185-90.

PMID:
21218606
17.

Neoadjuvant 5-FU or Capecitabine Plus Radiation With or Without Oxaliplatin in Rectal Cancer Patients: A Phase III Randomized Clinical Trial.

Allegra CJ, Yothers G, O'Connell MJ, Beart RW, Wozniak TF, Pitot HC, Shields AF, Landry JC, Ryan DP, Arora A, Evans LS, Bahary N, Soori G, Eakle JF, Robertson JM, Moore DF Jr, Mullane MR, Marchello BT, Ward PJ, Sharif S, Roh MS, Wolmark N.

J Natl Cancer Inst. 2015 Sep 14;107(11). pii: djv248. doi: 10.1093/jnci/djv248. Print 2015 Nov. Erratum in: J Natl Cancer Inst. 2016 Apr;108(4). pii: djw057. doi: 10.1093/jnci/djw057.

18.

Adjuvant therapy of colorectal cancer.

Kemeny N, Saltz L, Cohen A.

Surg Oncol Clin N Am. 1997 Oct;6(4):699-722. Review.

PMID:
9309089
19.

Radiotherapy and oral capecitabine in the preoperative treatment of patients with rectal cancer: rationale, preliminary results and perspectives.

Corvò R, Pastrone I, Scolaro T, Marcenaro M, Berretta L, Chiara S.

Tumori. 2003 Jul-Aug;89(4):361-7. Review.

PMID:
14606636
20.

[Chemotherapy for colorectal cancers].

Lièvre A, Mitry E.

J Chir (Paris). 2003 Feb;140(1):52-5. Review. French.

PMID:
12709655

Supplemental Content

Support Center